When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - Here's Why Karyopharm Therapeutics Has a Unique Growth Opportunity
Johnson & Johnson
Cancer-drug maker Karyopharm Therapeutics(NASDAQ: KPTI) has seen phenomenal growth since early 2019, with its stock up more than 60% in a bit more than a year.
The 12-year-old company is pioneering novel drugs that will help treat patients with certain blood cancers or solid tumors. Over the past six months alone, the stock has generated gains of 72%. So what's generating all this buzz?